Join
Live feed
·
PRReleasevia Quantisnow
Alaunos Therapeutics Inc. logo

Alaunos Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies

ByQuantisnow·Wall Street's wire, on your screen.
TCRT· Alaunos Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TCRT (Alaunos Therapeutics Inc.) and more on Quantisnow.